Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with
hyperlipidemia
- 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose,
noninferiority, multicenter, phase 4 design